(PharmaNewsWire.Com, September 22, 2017 ) The Middle East and Africa Vascular Closure Devices Market was worth USD 52.65 Million in 2016 and is estimated to be growing at a CAGR of 5.5%, to reach USD 68.8 Million by 2021. Vascular closure devices are the devices which are used to stop the blood flow from the puncture made on femoral artery after certain diagnostic procedures. Large incisions are required for cardiovascular surgeries to replace valves in the heart.
Manual compression is not a good option during these surgeries. Vascular closure devices increase the comfort and reduce discharge time for patients and they can be used with ease. They reduce lot of time and effort for physicians and further supervision is not required. Technological advancements resulted in novel materials which degrade after short period of time.
Increasing awareness of minimally invasive surgeries, rising number of angiography procedures, large geriatric population who require valve replacements are the major factors driving the market. Technological advancements and ease with which VCDs can be used are also propelling the market. However, certain risks involved with the use of VCDs such as groin infections and other disadvantages and rising costs of devices are restraining the market.
The Middle East and Africa vascular closure devices market is categorized based on the type, access, procedure, end user and by region. Based on the type of devices, the market is categorized into passive approximators, Active Approximators and External Hemostatic Devices. Active approximators segment is projected to hold the largest share in the VCDs market due to their high efficiency. Passive approximators are again categorized into Sealant or Gel based devices, Collagen plugs and Compression assist devices. Active approximators are again categorized into Suture based devices and clip based devices. Based on access to the artery, the market is categorized into Femoral and radial access. Femoral access the largest market share because it is largely adopted by physicians around the globe. Based on procedure involved, the market is categorized into interventional cardiology and interventional radiology or vascular surgery. Based on end user, the market is categorized into acute care facilities, hospitals and clinics. Acute care facilities are the largest market segment due to the increase of emergency cases in cardiovascular diseases.
The vascular closure devices market in this region is analyzed under Middle East and Africa regions. Rising prevalence of cancer and increasing focus of major players to expand in this region are expected to drive the market in this region.
Abbott Vascular, Cardinal Health, Merit Medical Systems, Inc., Biotronik GMBH & CO.KG, Medtronic, Boston Scientific Corporation, Essential Medical, Inc., Cardival Medical, Inc., W L. Gore & Associates; St. Jude Medical, TZ Medical, Inc. and Scion BioMedical are some of the key players in VCDs market.
About Us: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
